MALVERN, Pa. & KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Marillion Pharmaceuticals Inc and Cytokine PharmaSciences Inc (CPSI) announced today that the two companies have entered into a license agreement granting Marillion exclusive worldwide rights to develop and commercialize CPSI’s Pilobuc™ buccal insert for the treatment of xerostomia.
